Subbu Nambi
Stock Analyst at Guggenheim
(3.40)
# 1,248
Out of 5,182 analysts
77
Total ratings
44.12%
Success rate
6.74%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Buy | $275 → $235 | $180.62 | +30.11% | 4 | Apr 22, 2026 | |
| BRKR Bruker | Maintains: Buy | $58 → $50 | $36.53 | +36.87% | 6 | Mar 30, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $120 → $100 | $81.76 | +22.31% | 2 | Mar 30, 2026 | |
| GRAL GRAIL | Maintains: Buy | $130 → $75 | $55.02 | +36.31% | 4 | Mar 30, 2026 | |
| TEM Tempus AI | Maintains: Buy | $95 → $60 | $52.68 | +13.90% | 5 | Mar 30, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $50 → $55 | $61.00 | -9.84% | 4 | Mar 30, 2026 | |
| VCYT Veracyte | Maintains: Buy | $50 → $45 | $33.85 | +32.94% | 6 | Mar 30, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $170 → $100 | $66.17 | +51.13% | 3 | Mar 30, 2026 | |
| NAUT Nautilus Biotechnology | Maintains: Buy | $2.5 → $4 | $2.57 | +55.64% | 2 | Feb 27, 2026 | |
| WAT Waters | Reiterates: Buy | $440 | $299.79 | +46.77% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.86 | +44.03% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $13 | $5.96 | +118.12% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $144 → $170 | $128.52 | +32.28% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $88.50 | +52.54% | 8 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $24.98 | +88.15% | 3 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $14.21 | +47.78% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $9.45 | +26.98% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $204.39 | +32.10% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $86.80 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $19.93 | +80.63% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $10.38 | -3.66% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.83 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.28 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $118.29 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.59 | - | 1 | Dec 14, 2023 |
Danaher
Apr 22, 2026
Maintains: Buy
Price Target: $275 → $235
Current: $180.62
Upside: +30.11%
Bruker
Mar 30, 2026
Maintains: Buy
Price Target: $58 → $50
Current: $36.53
Upside: +36.87%
BillionToOne
Mar 30, 2026
Maintains: Buy
Price Target: $120 → $100
Current: $81.76
Upside: +22.31%
GRAIL
Mar 30, 2026
Maintains: Buy
Price Target: $130 → $75
Current: $55.02
Upside: +36.31%
Tempus AI
Mar 30, 2026
Maintains: Buy
Price Target: $95 → $60
Current: $52.68
Upside: +13.90%
Twist Bioscience
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $55
Current: $61.00
Upside: -9.84%
Veracyte
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $45
Current: $33.85
Upside: +32.94%
GeneDx Holdings
Mar 30, 2026
Maintains: Buy
Price Target: $170 → $100
Current: $66.17
Upside: +51.13%
Nautilus Biotechnology
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $2.57
Upside: +55.64%
Waters
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $299.79
Upside: +46.77%
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $4.86
Upside: +44.03%
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $5.96
Upside: +118.12%
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $128.52
Upside: +32.28%
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $88.50
Upside: +52.54%
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $24.98
Upside: +88.15%
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $14.21
Upside: +47.78%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $9.45
Upside: +26.98%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $204.39
Upside: +32.10%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $86.80
Upside: -
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $19.93
Upside: +80.63%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $10.38
Upside: -3.66%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.83
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $22.28
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $118.29
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.59
Upside: -